Autoimmunity BioSolutions
Autoimmunity BioSolutions is a biotechnology company focused on developing next-generation immuno-corrective therapies for patients with autoimmune diseases. The company targets a genetically-defined subpopulation, aiming to address the underlying causes of these conditions with innovative treatments.
Leadership & Board
- Current Number of Employees
- 7
- Current LinkedIn Followers
- 200
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $2M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $2M
- Latest Funding Round
- Seed Round
- Post-Money Valuation
- ―
Employee Trend
Autoimmunity BioSolutions had 7 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.
7Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Autoimmunity BioSolutions had 200 followers as of October 12, 2026. The number of followers increased by 1 (0.50%) week-over-week.
200Latest Followers Count
1(0.50%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 14, 2025 | Seed Round | $2.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Alexandria Venture Investments | Seed Round |
| Eos BioInnovation | Seed Round |
| Independent Capital | Seed Round |
Similar Companies
A snapshot of private companies similar to Autoimmunity BioSolutions, helping you discover and navigate related company profiles.
Related News and Analysis
